Together, these findings demonstrate that spike-specific CXCR3+ and CXCR3− TFH cells exhibit distinct kinetics, and that spike-specific CXCR3+ TFH cell responses may persist for more than 2 years in COVID-19 convalescents. The gene discussed is CXCR3; the disease is COVID-19.